References
- Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev 1987; 96: 23
- Allen D., Cumano A., Dildrop R., Kocks C., Rajewsky K., Rajewsky N., Roes J., Sablitzky E., Siekevitz M. Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development. Immunol. Rev 1987; 96: 5
- Berek C., Milstein C. The dynamic nature of the antibody repertoire. Immunol. Rev 1988; 105: 5
- Pluckthun A. Antibodies from. Escherichia coli. Nature 1990; 237: 497
- Winter G., Milstein C. Man-made antibodies. Nature 1991; 349: 293
- Marks J. D., Griffiths A. D., Malmqvist M., Clackson T. P., Bye J. M., Winter G. Bypassing immunization: building high affinity human antibodies by chain shuffling. Bioltechnology 1992; 10: 779
- Gram H., Marconi L. -A., Barbas C. E., Collet T. A., Lerner R. A., Kang A. S. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc. Natl. Acad. Sci. USA 1992; 89: 3576
- Glaser S. M., Yelton D. E., Huse W. D. Antibody engineering by codon-based mutagenesis in a filamentous phage vector system. J. Immunol 1992; 149: 3903
- Reidhaar-Olson J. F., Sauer R. T. Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences. Science 1988; 241: 53
- Derbyshire K. M., Salvo J. J., Grindley N. D.F. A simple and efficient procedure for saturation mutagenesis using mixed oligodeoxynucleotides. Gene 1986; 46: 145
- Chothia C., Lesk A. M., Tramontane A., Levitt M., Smith-Gill S. J., Air G., Sheriff S., Padlan E. A., Davies D., Tulip W R., Colman P. M., Spinelli S., Alzari P. M., Poljak R. J. Conformation of immunoglobulin hypervariable regions. Nature 1989; 342: 877
- Huse W. D. Combinatorial antibody expression libraries in filamentous phase. Antibody Engineering: A Practical Guide, C. A. K. Borrebaeck. W. H. Freeman and Company, New York 1991; 103–120
- Huse W. D., Stinchcombe T. J., Glaser S. M., Starr L., MacLean M., Hellström K. E., Hellström I., Yelton D. E. Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening and mutagenesis of F(ab) antibody fragments. J. Immunol 1992; 149: 3914
- Hellstrom I., Home D., Linsley R., Brown J. P., Brankovan V., Hellström K. E. Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res 1986; 46: 3917
- Hellström I., Beaumier P. L., Hellström K. E. Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas. Proc. Natl. Acad. Sci. USA 1986; 83: 7059
- Liu A. Y., Robinson R. R., Hellström K. E., Murray E. D., Jr., Chang C. P., Hellström I. Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc. Natl. Acad. Sci. USA 1987; 84: 3439
- Fell H. P., Gayle M. A., Yelton D., Lipsich L., Schieven G. L., Marken J. S., Aruffo A., Hellström K. E., Hellström I., Bajorath J. Chimeric L6 anti-tumor antibody. J. Biol. Chem 1992; 267: 15552
- Goodman G. E., Hellström I., Brodzinsky L., Nicaise C., Kulander B., Hummel D., Hellström K. E. Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J. Clin. Oncol 1990; 8: 1083
- Hellström K. E., Yelton D. E., Fell H. R., Beaton D., Gayle M., MacLean M., Kahn M., Hellström I. Epitope mapping and use of anti-idiotype antibodies to the L6 monoclonal anticarcinoma antibody. Cancer Res 1990; 50: 2449
- Jonsson U., Fagerstam L., Ivarsson B., Johnsson B., Karlsson R., Lundh K., Lofas S., Persson B., Roos H., Ronnberg I., Sjolander S., Stenberg E., Stahlberg R., Urbaniczky C., Ostlin H., Malmqvist M. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Bio Techniques 1991; 11: 620
- Sharon J. Structural correlates of high antibody affinity: Three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold. Proc. Natl. Acad. Sci. USA 1990; 87: 4814
- Morrison S. L., Wims L., Wallick S., Tan L., Oi V T. Genetically engineered antibody molecules and their application. Biological Approaches to the Controlled Delivery of Drugs, R. L. Juliano. Ann. N. Y. Acad. Sci., 1987; 507: 187
- Mayforth R. D., Quintans J. Designer and catalytic antibodies. N. Engl. J. Med 1990; 323: 173
- Rodwell J. D. Engineering monoclonal antibodies. Nature 1989; 342: 99
- Waldmann T. A. Monoclonal antibodies in diagnosis and therapy. Science 1991; 252: 1657